Delphia (USA) Inc. - RECURSION PHARMACEUTICALS IN ownership

RECURSION PHARMACEUTICALS IN's ticker is RXRX and the CUSIP is 75629V104. A total of 157 filers reported holding RECURSION PHARMACEUTICALS IN in Q2 2023. The put-call ratio across all filers is 0.96 and the average weighting 1.1%.

Quarter-by-quarter ownership
Delphia (USA) Inc. ownership history of RECURSION PHARMACEUTICALS IN
ValueSharesWeighting
Q2 2023$76,284
-56.8%
10,212
-61.4%
0.12%
-44.4%
Q1 2023$176,555
+18.5%
26,470
+44.8%
0.22%
+109.7%
Q2 2022$149,00018,2810.10%
Other shareholders
RECURSION PHARMACEUTICALS IN shareholders Q2 2023
NameSharesValueWeighting ↓
CRV, LLC 733,986$26,790,00044.35%
MIC CAPITAL PARTNERS (PUBLIC) (US) IM, LLC 1,388,889$50,694,446,0009.21%
Samsara BioCapital, LLC 775,583$28,309,0003.50%
HARVARD MANAGEMENT CO INC 1,509,254$55,088,0003.17%
Laurion Capital Management LP 3,858,617$140,839,0000.78%
Casdin Capital, LLC 548,156$20,008,0000.51%
ALLEN OPERATIONS LLC 68,104$2,486,0000.43%
PLATINUM INVESTMENT MANAGEMENT LTD 472,552$17,248,0000.40%
Ratan Capital Management LP 110,000$4,015,0000.35%
Comprehensive Financial Management LLC 1,109,395$40,493,0000.34%
View complete list of RECURSION PHARMACEUTICALS IN shareholders